Skip to main content
Fig. 3 | BMC Medical Genomics

Fig. 3

From: Comprehensive analysis of SPAG1 expression as a prognostic and predictive biomarker in acute myeloid leukemia by integrative bioinformatics and clinical validation

Fig. 3

The impact of SPAG1 expression on survival of AML patients with specific subtypes. a Kaplan–Meier survival curves of overall survival and disease/leukemia free survival in whole-cohort AML and CN-AML without FLT3 mutation from TCGA datasets. b Kaplan–Meier survival curves of overall survival and disease/leukemia free survival in whole-cohort AML and CN-AML without DNMT3A mutation from TCGA datasets. c Kaplan–Meier survival curves of overall survival and disease/leukemia free survival in whole-cohort AML and CN-AML without WT1 mutation from TCGA datasets. d Kaplan–Meier survival curves of overall survival and disease/leukemia free survival in whole-cohort AML and CN-AML without FLT3/DNMT3A/WT1 mutation from TCGA datasets

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us